UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Treatment of acid-fast bacterial infection based on the PK/PD theory

Kekkaku, 2010-12, Vol.85 (12), p.853

Hanada, Kazuhiko

2010

Volltextzugriff (PDF)

Comparison of inhibitory effect of rifalazil and rifampicin against Mycobacterium ulcerans infection induced in mice

Kekkaku, 2004-05, Vol.79 (5), p.333

2004

Volltextzugriff (PDF)

Therapeutic effects of benzoxazinorifamycin KRM-1648 administered alone or in combination with glycyrrhizin against Mycobacterium avium complex infection in mice

Kekkaku, 1999-08, Vol.74 (8), p.617

1999

Volltextzugriff (PDF)

New drugs against tuberculosis and nontuberculous mycobacterial infections: a review

Kekkaku, 1994-11, Vol.69 (11), p.711

1994

Volltextzugriff (PDF)

A putative immunotherapy with biological response modifiers (BRM) against intractable pulmonary tuberculosis

Kekkaku, 2001-12, Vol.76 (12), p.741

Saito, A

2001

Volltextzugriff (PDF)

Studies on therapeutic efficacy of a new anti-tuberculous drug, benzoxazinorifamycin, against murine experimental mycobacterial infections: attempt at various regimens and protocols

Kekkaku, 1994-11, Vol.69 (11), p.703

1994

Volltextzugriff (PDF)

In vivo activities of benzoxazinorifamycin KRM-1648, clarithromycin, and levofloxacin, or combination of KRM-1648 with diclofenac sodium against Mycobacterium avium infection induced in mice

Kekkaku, 1997-08, Vol.72 (8), p.491

1997

Volltextzugriff (PDF)

Expectation of new antituberculous drugs and targeting therapy for treatment of mycobacterial infections

Kekkaku, 1993-11, Vol.68 (11), p.723

Tomioka, H

1993

Volltextzugriff (PDF)

Therapeutic efficacy of a benzoxazinorifamycin, KRM-1648, combined with a immunopotentiator, LC9018, in Mycobacterium intracellulare infection induced in beige mice

Kekkaku, 1993-12, Vol.68 (12), p.751

1993

Volltextzugriff (PDF)

Therapeutic efficacy of benzoxazinorifamycin KRM-1648 against experimental murine tuberculosis: (1). A study on the efficacy of short course treatment with the intratracheal and intravenous infection model

Kekkaku, 1998-02, Vol.73 (2), p.53

Doi, N

1998

Volltextzugriff (PDF)

Establishment of the quantitative intratracheal infection model of experimental murine mycobacteriosis

Kekkaku, 1999-02, Vol.74 (2), p.121

Doi, N

1999

Volltextzugriff (PDF)

Therapeutic efficacy of a benzoxazinorifamycin, KRM-1648, administered at the different periods of infection in Mycobacterium intracellulare--infected mice

Kekkaku, 1993-10, Vol.68 (10), p.631

1993

Volltextzugriff (PDF)

In vivo activities of new rifamycin derivatives against mycobacteria

Kekkaku, 1991, Vol.66 (1), p.7

1991

Volltextzugriff (PDF)

Effectiveness and problems of PZA-containing 6-month regimen for the treatment of new pulmonary tuberculosis patients

Kekkaku, 2001-01, Vol.76 (1), p.33

Wada, M

2001

Volltextzugriff (PDF)

In vitro antimycobacterial activity of clarithromycin and its therapeutic efficacy against Mycobacterium intracellulare infection induced in mice

Kekkaku, 1993-04, Vol.68 (4), p.293

1993

Volltextzugriff (PDF)

Therapeutic efficacy of kanamycin and clofazimine combined with muramyl dipeptide against Mycobacterium intracellulare infection induced in mice

Kekkaku, 1991-12, Vol.66 (12), p.811

1991

Volltextzugriff (PDF)

The latest topics concerning pyrazinamide

Kekkaku, 1985-11, Vol.60 (11), p.585

1985

Volltextzugriff (PDF)

Chemotherapy of tuberculosis in various countries

Kekkaku, 1985-06, Vol.60 (6), p.343

Iwasaki, T

1985

Volltextzugriff (PDF)

Pharmacodynamics of rifampicin--bacteriological and pharmacological action of rifampicin

Kekkaku, 1979-12, Vol.54 (12), p.576

Toyohara, M

1979

Volltextzugriff (PDF)

A study on drug regimens against Mycobacterium avium-intracellulare infection. (2). The therapeutic effects of aminoglycosides on a murine airborne infection model

Kekkaku, 1987-07, Vol.62 (7), p.369

1987

Volltextzugriff (PDF)

Experimental studies on the effective regimens of antituberculous drugs in the treatment of tuberculosis. I. Intermittent drug administration and single or combined drugs

Kekkaku, 1977-07, Vol.52 (7), p.339

1977

Volltextzugriff (PDF)

Overview on preclinical research on tuberculosis chemotherapy in the past 100 years. (2) Experimental studies following clinical tests

Kekkaku, 1983-04, Vol.58 (4), p.235

1983

Volltextzugriff (PDF)

Preclinical study of therapeutic agents used against Mycobacterium avium complex infections--with special reference to new macrolides and new quinolones

Kekkaku, 1996-09, Vol.71 (9), p.531

1996

Volltextzugriff (PDF)

A study on drug regimens against Mycobacterium avium-intracellulare infection (3). The therapeutic effect of some antimicrobial agents to murine infection model

Kekkaku, 1988, Vol.63 (6), p.447

Sakurai, N

1988

Volltextzugriff (PDF)

Primary drug resistance in tuberculosis

Kekkaku, 1968-08, Vol.43 (8), p.343

1968

Volltextzugriff (PDF)

1 – 25 von 66

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieTuberculosis

SpracheEnglisch

Zeitschrift / SerieKekkaku

ThemaAnimals

Suchergebnisse filtern

Filter anzeigen

Publikationsform

Artikel
(66)

Sprache

Japanisch
(66)

Erscheinungsjahr

n.n

Kollektion

MEDLINE
(66)

Zeitschrift / Serie

結核
(8)
Kekkaku : [tuberculosis]
(1)

Menü

Weitere Dienste

Einstellungen

Treatment of acid-fast bacterial infection based on the PK/PD theory

Comparison of inhibitory effect of rifalazil and rifampicin against Mycobacterium ulcerans infection induced in mice

Therapeutic effects of benzoxazinorifamycin KRM-1648 administered alone or in combination with glycyrrhizin against Mycobacterium avium complex infection in mice

New drugs against tuberculosis and nontuberculous mycobacterial infections: a review

A putative immunotherapy with biological response modifiers (BRM) against intractable pulmonary tuberculosis

Studies on therapeutic efficacy of a new anti-tuberculous drug, benzoxazinorifamycin, against murine experimental mycobacterial infections: attempt at various regimens and protocols

In vivo activities of benzoxazinorifamycin KRM-1648, clarithromycin, and levofloxacin, or combination of KRM-1648 with diclofenac sodium against Mycobacterium avium infection induced in mice

Expectation of new antituberculous drugs and targeting therapy for treatment of mycobacterial infections

Therapeutic efficacy of a benzoxazinorifamycin, KRM-1648, combined with a immunopotentiator, LC9018, in Mycobacterium intracellulare infection induced in beige mice

Therapeutic efficacy of benzoxazinorifamycin KRM-1648 against experimental murine tuberculosis: (1). A study on the efficacy of short course treatment with the intratracheal and intravenous infection model

Establishment of the quantitative intratracheal infection model of experimental murine mycobacteriosis

Therapeutic efficacy of a benzoxazinorifamycin, KRM-1648, administered at the different periods of infection in Mycobacterium intracellulare--infected mice

In vivo activities of new rifamycin derivatives against mycobacteria

Effectiveness and problems of PZA-containing 6-month regimen for the treatment of new pulmonary tuberculosis patients

In vitro antimycobacterial activity of clarithromycin and its therapeutic efficacy against Mycobacterium intracellulare infection induced in mice

Therapeutic efficacy of kanamycin and clofazimine combined with muramyl dipeptide against Mycobacterium intracellulare infection induced in mice

The latest topics concerning pyrazinamide

Chemotherapy of tuberculosis in various countries

Pharmacodynamics of rifampicin--bacteriological and pharmacological action of rifampicin

A study on drug regimens against Mycobacterium avium-intracellulare infection. (2). The therapeutic effects of aminoglycosides on a murine airborne infection model

Experimental studies on the effective regimens of antituberculous drugs in the treatment of tuberculosis. I. Intermittent drug administration and single or combined drugs

Overview on preclinical research on tuberculosis chemotherapy in the past 100 years. (2) Experimental studies following clinical tests

Preclinical study of therapeutic agents used against Mycobacterium avium complex infections--with special reference to new macrolides and new quinolones

A study on drug regimens against Mycobacterium avium-intracellulare infection (3). The therapeutic effect of some antimicrobial agents to murine infection model

Primary drug resistance in tuberculosis

Aktive Filter

Suchergebnisse filtern